Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Venous Thromboembolism × apixaban × Myeloid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 18 Plasma cell 4 Other hematologic neoplasm 1 Myeloid 1 Lymphoid 1

Conditions

Myeloproliferative Disorders 2 Venous Thromboembolism 1 Thrombocythemia, Essential 1 Primary Myelofibrosis 1 Polycythemia Vera 1

Interventions

Aspirin 2 apixaban 1 Tinzaparin 1 Tablets 1 Platelet Transfusion 1 Observation 1 N(4)-oleylcytosine arabinoside 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04243122 2024-05-29

AIRPORT-MPN

Ottawa Hospital Research Institute

Phase 2 Completed

Classical hematologyMyeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Venous Thromboembolism, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡